[The HIV virus used as antileukemic vector].
jeanyves.nau@gmail.com
Jean-Yves
JY
Nau
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004337:Drug Carriers / Q000627:therapeutic use*; D015316:Genetic Therapy; D005822:Genetic Vectors / Q000008:administration & dosage / Q000627:therapeutic use; D015497:HIV-1 / Q000276:immunology / Q000502:physiology*; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods; D016086:Lentivirus / Q000235:genetics; D007938:Leukemia / Q000628:therapy*; D013602:T-Lymphocytes, Cytotoxic / Q000378:metabolism / Q000637:transplantation
D000970:Antineoplastic Agents; D004337:Drug Carriers